Tri Locum Partners’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-208,250
| Closed | -$6.81M | – | 59 |
|
|
2023
Q3 | $6.81M | Buy |
208,250
+71,585
| +52% | +$2.34M | 2.18% | 16 |
|
|
2023
Q2 | $7.95M | Buy |
136,665
+7,382
| +6% | +$430K | 2.96% | 13 |
|
|
2023
Q1 | $3.37M | Buy |
129,283
+5,732
| +5% | +$150K | 1.03% | 28 |
|
|
2022
Q4 | $3.68M | Buy |
123,551
+40,084
| +48% | +$1.19M | 1.49% | 22 |
|
|
2022
Q3 | $4.28M | Buy |
83,467
+25,524
| +44% | +$1.31M | 1.18% | 28 |
|
|
2022
Q2 | $1.68M | Buy |
57,943
+690
| +1% | +$20K | 0.69% | 29 |
|
|
2022
Q1 | $3.01M | Buy |
57,253
+4,621
| +9% | +$243K | 1.17% | 27 |
|
|
2021
Q4 | $3.62M | Buy |
+52,632
| New | +$3.62M | 1.42% | 19 |
|